Patent · US Active

Long circulating nanoparticles for sustained release of therapeutic agents

US9198874B2 · kind B2 · utility

1Cited by
35References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2013
Grant dateDec 1, 2015
Priority date
Expiry dateDec 9, 2033

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed in part to a biocompatible nanoparticle composition comprising a plurality of non-colloidal long circulating nanoparticles, each comprising a α-hydroxy polyester-co-polyether and a therapeutic agent, wherein such disclosed compositions provide a therapeutic effect for at least 12 hours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.